Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Kathleen A Neville"'
Autor:
Alejandro Parrales, Peter McDonald, Megan Ottomeyer, Anuradha Roy, Frank J Shoenen, Melinda Broward, Tyce Bruns, Douglas H Thamm, Scott J Weir, Kathleen A Neville, Tomoo Iwakuma, Joy M Fulbright
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194224 (2018)
BACKGROUND:Osteosarcoma is an orphan disease for which little improvement in survival has been made since the late 1980s. New drug discovery for orphan diseases is limited by the cost and time it takes to develop new drugs. Repurposing already approv
Externí odkaz:
https://doaj.org/article/fcfb7274e7014e86bedf45880a5e58f5
Autor:
Nancy S Green, Katherine L Ender, Farzana Pashankar, Catherine Driscoll, Patricia J Giardina, Craig A Mullen, Lorraine N Clark, Deepa Manwani, Jennifer Crotty, Sergey Kisselev, Kathleen A Neville, Carolyn Hoppe, Sandra Barral
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55709 (2013)
Fetal hemoglobin level is a heritable complex trait that strongly correlates swith the clinical severity of sickle cell disease. Only few genetic loci have been identified as robustly associated with fetal hemoglobin in patients with sickle cell dise
Externí odkaz:
https://doaj.org/article/b92ea4c772dc4035bd0462f3b0f400f6
Autor:
Xiaobo Liang, Jon B. Klein, Kathleen A. Neville, Atif A. Ahmed, Safinur Atay, Vincent S. Staggs, Jennifer Crow, Michael L. Merchant, Kris Laurence, Devin C. Koestler, Andrew K. Godwin, Glenson Samuel, Emily Nissen
Publikováno v:
Oncotarget
Purpose Ewing Sarcoma Family of Tumors (ESFT), the second most common pediatric osseous malignancy, are characterized by the pathognomonic chromosomal EWS-ETS translocation. Outside of tumor biopsy, no clinically relevant ESFT biomarkers exist. Addit
Autor:
Rohit Shenoi, Shannon C. Phillips, Sandra P. Spencer Cockerham, Ian M. Paul, Richard N. Shiffman, Bridgette L. Jones, Sean P. Gleeson, Kathleen A. Neville, Wayne H. Franklin, Laura Elizabeth Ferguson, Joel S. Tieder, Michael G. Leu, Matthew M. Laughon, Janice E. Sullivan, Jeffrey M. Brown, Thomas P. Green, Constance S. Houck, John R. Reigart, Elizabeth V. Saarel, Kathleen Mack Walsh, Philip A. Verhoef, Jennifer Foster, H. Shonna Yin, Michael L. Rinke, John N. van den Anker, Ricardo A. Quinonez, Francisco Alvarez, Adam C. Adler, Terry A. Adirim, David G. Bundy, Brigitta U. Mueller, Ulfat Shaikh, Corinna J. Rea, Daniel R. Neuspiel
Publikováno v:
Pediatrics. 148(6)
Medication administration errors that take place in the home are common, especially when liquid preparations are used and complex medication schedules with multiple medications are involved; children with chronic conditions are disproportionately aff
Autor:
Bilya Sani Musa, Muktar H. Aliyu, Adetola A. Kassim, Lori C. Jordan, Halima Bello-Manga, Fenella J Kirkham, Michael R. DeBaun, Matin Ghafuri, Abdulrasheed Sani, Holly Cassell, Shehu U. Abdullahi, Kathleen A. Neville, Safiya Gambo, Awwal Gambo, Djamila L. Ghafuri, Brittany Covert Greene, Binta J. Wudil
Publikováno v:
Pediatr Neurol
BackgroundNigeria has the highest proportion of children with sickle cell anemia (SCA) globally; an estimated 150,000 infants with SCA are born annually. Primary stroke prevention in children with SCA must include Nigeria. We describe capacity-buildi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff691a93e678708a05f6759a4b85664
https://europepmc.org/articles/PMC8559257/
https://europepmc.org/articles/PMC8559257/
Autor:
Faith Cisneros, Austin Christofferson, Deanna Mitchell, Jawhar Rawwas, Don E Eslin, Randal K. Wada, Javier Oesterheld, Genevieve Bergendahl, Xinyu Wen, Jun S. Wei, Hue V. Reardon, Tyler Izatt, Jeffrey M. Trent, William Roberts, William P.D. Hendricks, Virginia L Harrod, Karl Dykema, Sara Nasser, Sara A. Byron, Elizabeth VanSickle, Bryce Turner, Jacqueline M. Kraveka, Peter E. Zage, Alison Roos, Apurva M. Hegde, Valerie I. Brown, Kathleen A. Neville, Albert Cornelius, Jonathan J Keats, Szabolcs Szelinger, Rebecca F. Halperin, Michael S. Isakoff, William S. Ferguson, Daniel Enriquez, Javed Khan, Abhinav Nagulapally, Jeffrey P. Bond, Hsien-Chao Chou, Giselle Saulnier Sholler
Publikováno v:
Cancer Res
Cancer research, vol 81, iss 23
Cancer research, vol 81, iss 23
Children with treatment-refractory or relapsed (R/R) tumors face poor prognoses. As the genomic underpinnings driving R/R disease are not well defined, we describe here the genomic and transcriptomic landscapes of R/R solid tumors from 202 patients e
Autor:
Kathleen A. Neville, Brittany Covert Greene, Raymond Belonwu, Awwal Musa Borodo, Muhammad S. Abba, Aisha Amal Galadanci, Auwal Salihu, Aliyu Tijjani, Shehu U. Abdullahi, Binta W. Jibir, Adetola A. Kassim, Muktar H. Aliyu, Najibah A. Galadanci, Hauwa Aminu, Lori C. Jordan, Fenella J. Kirkham, Djamila L. Ghafuri, Musa A. Tabari, Mark Rodeghier, Shehi Abubakar, Michael R. DeBaun
Publikováno v:
Am J Hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52297a8fe1549726b875cefa44c4b7f7
https://eprints.soton.ac.uk/445911/
https://eprints.soton.ac.uk/445911/
Autor:
Susan Sencer, Deanna Mitchell, Jessica Foley, Randal K. Wada, Joseph Junewick, Jeffrey P. Bond, Debra Pankiewicz, William Roberts, Monique Quinn, Jawhar Rawwas, William S. Ferguson, Javier Oesterheld, Giselle Saulnier Sholler, Jacqueline M. Kraveka, Valerie I. Brown, Kathleen A. Neville, Don Eslin, Francis Eshun, Genevieve Bergendahl, Peter E. Zage, Maria Rich, Nehal Parikh
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific reports, vol 8, iss 1
Sholler, Giselle L Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P; Neville, Kathleen; Eslin, Don; et al.(2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. SCIENTIFIC REPORTS, 8(1), 14445. doi: 10.1038/s41598-018-32659-w. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/4z74d9zw
Scientific reports, vol 8, iss 1
Sholler, Giselle L Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P; Neville, Kathleen; Eslin, Don; et al.(2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. SCIENTIFIC REPORTS, 8(1), 14445. doi: 10.1038/s41598-018-32659-w. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/4z74d9zw
High risk neuroblastoma (HRNB) accounts for 15% of all pediatric cancer deaths. Despite aggressive therapy approximately half of patients will relapse, typically with only transient responses to second-line therapy. This study evaluated the ornithine
Autor:
Sarah H. O'Brien, Jane S. Hankins, Susan E Creary, Kathleen A. Neville, Uttam Garg, Deena J. Chisolm, Joseph Stanek
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(8)
Background Hydroxyurea nonadherence is common among children with sickle cell disease (SCD), but it is unclear if current adherence measures are valid compared with video directly observed therapy (VDOT), a reference method. The objectives were to ev
Autor:
Paweł Wiczling, Joseph Moen, Julie A. Panepinto, Joana M. Mack, Jeremie H. Estepp, Uttam Garg, Guolian Kang, Kathleen A. Neville, Gregory L. Kearns, Robert I. Liem
Publikováno v:
British Journal of Clinical Pharmacology. 84:1478-1485
Aims The purpose of this work was to (1) compare pharmacokinetic (PK) parameters for hydroxycarbamide in children receiving their first dose (HCnew) versus those receiving chronic therapy (HCchronic), (2) assess the external validity of a published P